 Integrated host/microbe metagenomics enables accurate lower respiratory tract infection diagnosis in critically ill children JCI, 2023
|
 Successful Treatment of Balamuthia mandrillaris Granulomatous Amebic Encephalitis with Nitroxoline Emerging Infectious Diseases, 2023
|
 Dual ankyrinG and subpial autoantibodies in a man with well-controlled HIV infection with steroid-responsive meningoencephalitis: A case report Frontiers, 2023
|
 Antibodies to repeat-containing antigens in Plasmodium falciparum are exposure-dependent and short-lived in children in natural malaria infections eLife, 2023
|
 Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges PLOS One, 2023
|
 Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients JCI Insight, 2023
|
 Computational pipeline provides mechanistic understanding of Omicron variant of concern neutralizing engineered ACE2 receptor traps Science Direct, 2023
|
|  Scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and University of California, San Francisco (UCSF), have discovered an autoimmune disease that appears to affect men with testicular cancer. A postdoctoral fellow in the DeRisi lab, Caleigh Mandel-Brehm, led the study together with a clinical fellow at the Mayo Clinic, Divyanshu Dubey. Using a combination of customized programmable phage display, immunohistochemical staining, and other techniques, antibodies to the protein Kelch-like Protein 11 (KLHL11) was identified as a highly specific marker of a new paraneoplastic autoimmune syndrome associated with seminoma in men. Click Here for the Full Press Release |
|
